Lofexidine versus clonidine for mitigation of opioid withdrawal symptoms: A systematic review-Reference-Cited by-同舟云学术

Lofexidine versus clonidine for mitigation of opioid withdrawal symptoms: A systematic review

Published:2020-01 Issue:1 Volume:60 Page:145-152
ISSN:1544-3191
Container-title:Journal of the American Pharmacists Association
language:en
Short-container-title:Journal of the American Pharmacists Association

Author:

Kuszmaul Amanda K.,Palmer Emma C.,Frederick Emily K.

Publisher

Elsevier BV

Subject

Pharmacology,Pharmacy,Pharmacology (nursing)

Reference23 articles.

1. American Society of Addiction Medicine (ASAM) national practice guideline for the use of medications in the treatment of addiction involving opioid use;Kampman;J Addict Med,2015

2. Lucemyra (lofexidine) [package insert],2018

3. Catapres (clonidine hydrochloride) [prescribing information],2016

4. Clonidine in outpatient detoxification from methadone maintenance;Kleber;Arch Gen Psychiatry,1985

5. Efficacy of clonidine, guanfacine and methadone in the rapid detoxification of heroin addicts: a controlled clinical trial;San;Br J Addict,1990

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pannexin-1 channel inhibition alleviates opioid withdrawal in rodents by modulating locus coeruleus to spinal cord circuitry;Nature Communications;2024-07-24

2. An experimentally validated approach to automated biological evidence generation in drug discovery using knowledge graphs;Nature Communications;2024-07-08

3. Promising immunomodulators for management of substance and alcohol use disorders;Expert Opinion on Pharmacotherapy;2024-05-02

4. LOFEXIDINE;Prescriber's Guide;2024-04-18

5. Provision of health care services related to substance use disorder in southern U.S. jails;Journal of Substance Use and Addiction Treatment;2024-03